Live-attenuated Y. pestis vaccines protect against pneumonic plague, probably by generating both protective antibodies and protective T cells. These live vaccines raise significant safety concerns ...

Nurse consultant Linda Nazarko explains the new RSV vaccination programme and how nurses can support patients to understand ...

RSV also causes bronchiolitis, pneumonia ... the most advanced vaccine candidates: two formulations are now entering Phase I–IIa trials. MEDI-559 is a cold-passaged, live attenuated RSV that ...

The cost-effectiveness analysis will certainly evolve further; on 1 June, Gilead announced results from a phase 3 trial involving patients with moderate pneumonia resulting from COVID-19.

Aug. 9, 2024 — A new, two-step flu vaccination strategy that pairs intramuscular injection of a viral vectored flu vaccine with nasal spray administration of a novel attenuated live flu virus ...

Influenza B virus (IBV) stands as a paradox, often overshadowed by its more notorious counterpart, influenza A virus (IAV). Yet, it remains a captivating and elusive subject of scientific inquiry.

A total of 125 (4.3%) of 2890 patients enrolled in phase 3 trials received the HZ live-attenuated vaccine before randomisation ... one septic shock and cytomegalovirus infection, and two pneumonia), ...

WHO estimates over 90% of deaths attributed to influenza and pneumonia, its most common complication ... and in some countries live attenuated influenza vaccines are available [1]. Developments, such ...

The "Global Cholera Vaccines Market by Type (Inactivated Vaccine, Live Attenuated Vaccine), Method of Administration (Injectable Vaccines, Oral Vaccines), End User, Age Group - Forecast 2024-2030 ...

Indian Immunologicals and Griffith University have developed a live-attenuated intra-nasal COVID-19 booster vaccine, detailed in Nature Communications. Utilizing codon deoptimization technology ...